grants from the CAMS Innovation Fund for Medical Sciences (CIFMS)(No.2016-I2M-1-001);the National Natural Science Foundation of China (No.81172035);the National High Technology Research and Development Program of China (No.2012AA020206).
Biomarkers for hepatocellular carcinoma (HCC) following curative resection are not currently sufficient for prognostic indication of overall survival (OS) and disease-free survival (DFS). The aim of this study was to ...